Advanced Life Sciences Holdings, Inc. (NASDAQ: ADLS), a biopharmaceutical company, is focused discovering, developing, and commercializing novel drugs in the therapeutic areas of respiratory diseases, infection, and cancer. Cethromycin, the Company’s lead candidate, is a novel NDA-stage once-a-day oral antibiotic designed to treat respiratory tract infections, such as pneumonia. For further information, visit the Company’s web site at www.advancedlifesciences.com.
- 17 years ago
QualityStocks
Advanced Life Sciences Holdings, Inc. (NASDAQ: ADLS)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – BluSky AI Inc. (BSAI) Focused on Scalability in the Era of Artificial Intelligence
BluSky AI (OTC: BSAI) was featured in a recent article that discussed its strategic moves in…
-
QualityStocksNewsBreaks – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Advancing Louisiana SMC to Play Pivotal Role in Critical Mineral Supply Chain
Disseminated on behalf of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising.…
-
QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Releases New Datavault Insights Highlighting Execution, Growth and Global Momentum
Datavault AI (NASDAQ: DVLT) released a new Datavault Insights piece detailing the company’s ability to…